ライフサイエンスコーパス: penciclovir

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 RF 36, weakly sensitized cells to killing by penciclovir.

2 been confirmed as resistant to acyclovir and penciclovir.

3 Additionally, a radiolabeled analogue of penciclovir, [(18)F]FHBG, which is similar in structure

4 by thymidine kinase (TK) assay using 8-(3)H-penciclovir (8-(3)H-PCV) as substrate.

5 the radioactively labeled substrates [8-(3)H]penciclovir ([8-(3)H]PCV), and 8-[(18)F]fluoropenciclovi

6 Ex vivo substrate (8-3H Penciclovir) accumulation assays in 293T cells expressin

7 nce of adverse events was comparable between penciclovir and placebo groups.

8 -deoxyarabinofuranosyl-5-ethyluracil (FEAU), penciclovir, and 9-[4-fluoro-3-(hydroxymethyl)butyl]guan

9 curred both among patients who first applied penciclovir cream in the prodrome and erythema stages an

10 Penciclovir cream is the first treatment to clearly demo

11 Topical 1% penciclovir cream or vehicle control cream.

12 The efficacy of penciclovir cream was apparent when therapy was initiate

13 Subjects received topical penciclovir for 4 days during successive episodes of rec

14 lovir, an oral form of the purine nucleoside penciclovir, has been shown to inhibit HBV replication.

15 of these mutants to adefovir, lobucavir, and penciclovir in vitro and adefovir in vivo.

16 from these reactivations were susceptible to penciclovir in vitro.

17 mivudine]), and famciclovir (oral prodrug of penciclovir) induced depressions in viremia and intrahep

18 Famciclovir, the oral prodrug of penciclovir, inhibits HBV DNA replication.

19 e or lamivudine-resistant HBV to lamivudine, penciclovir, or adefovir but instead enhanced viral repl

20 Penciclovir (PCV), an antiherpesvirus agent in the same

21 is patient's HSV-2 isolates to acyclovir and penciclovir sensitivity, although resistant virus reappe

22 1.64; P=.003) also resolved more quickly for penciclovir-treated patients compared with patients who

23 lcers, and/or crusts) was 0.7 day faster for penciclovir-treated patients compared with those who rec

24 compared the inhibition constants (K(i)) of penciclovir triphosphate (PCVTP, the active metabolite o

25 triphosphate (FTCTP), adefovir diphosphate, penciclovir triphosphate, and lobucavir triphosphate was

26 Isolates remained sensitive to penciclovir when tested by a plaque reduction assay, and

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。